This is the intelligence company's fifth acquisition.
CorEvitas announced the acquisition of Pregistry LLC, a company focused on safety studies during pregnancy.
Pregistry utilizes 70 pregnancy experts to provide reports and studies on healthy pregnancies and births. The group collects data based on clinical, safety, regulatory, marketing, and technology needs and is then shared with individuals, providers, and industry stakeholders. This information is reportedly used by doctors as part of their decisions on what medications and vaccines to prescribe.
In a press release, Dr. Diego Wysznski, founder and chief executive officer of Pregistry, said, “For the last eight years, Pregistry has been a leader in the design and execution of pregnancy exposure registries to fulfill global regulatory commitments, such as mandates from the FDA and the EMA, and other observational studies in the maternal health field, including the world's largest pregnancy registries on COVID-19 vaccines and Covid treatments.”
CorEvitas is an intelligence company to provides a syndicated network of registries. Pregistry is its fifth acquisition.
Continue reading this story
